Enterprise Value

-11.94M

Cash

25.62M

Avg Qtr Burn

-25.53M

Short % of Float

0.59%

Insider Ownership

0.04%

Institutional Own.

11.94%

Qtr Updated

06/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
TNX-102 SL Details
Fibromyalgia

Big Mover™

Susp. Mover™

Phase 3

Data readout

TNX-1900 Details
Psychiatric disorder

Phase 2

Data readout

Phase 2

Data readout

TNX-1900 Details
Social Anxiety Disorder

Phase 2

Data readout

TNX-601 Details
Major depressive disorder

Phase 2

Data readout

Phase 2

Data readout

TNX-102 SL Details
Sleeping disorder, Post-traumatic stress disorder

Phase 2

Update

Phase 2

Update

TNX-1300 Details
Cocaine overdose / intoxication

Phase 2

Initiation

TNX-1500 Details
Kidney transplantation, Graft-versus-host disease , Hematopoietic cell transplantation

Phase 1

Data readout

TNX-102 SL Details
Agitation, Alzheimer's disease

Failed

Discontinued

TNX-102 SL Details
Alcohol dependence

Failed

Discontinued